Completed OBSERVATIONAL NCT01783093

Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia

An Evaluation of Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Patients With Sickle Cell Anemia: A Retrospective Data Review

Sponsor: Namita Sood

Conditions Pulmonary Hypertension Sickle Cell Anemia

Interventions Data Collection

Updated 6 times since 2017 Last updated: Jan 31, 2013 Started: Dec 31, 2009 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pulmonary Hypertension and Sickle Cell Anemia, this trial is completed. The trial is conducted by Namita Sood and has accumulated 6 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Namita Sood

Data source: Ohio State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States